Showing results (201-210 of 222) with videos related to
Sort By:
Pageof 23
Addictive Behaviors|May 28, 2026
Exploring fMRI-neurofeedback to reduce craving-related brain activity in people with cannabis use disorder: A feasibility studyEthan Murphy, Govinda Poudel, Amir Hossein Dakhili, et al.Journal of Substance Abuse Treatment|June 19, 2018
Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in SingaporeSong Guo, Victoria Manning, Yi Yang, et al.Drug and Alcohol Review|April 23, 2024
A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in AustraliaJoshua Trigg, Jane Rich, Edwina Williams, et al.Addiction (Abingdon, England)|November 11, 2022
Diagnostic accuracy for self-reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine-dependent intervention trial populationGregory Carter, Matthew J Spittal, Linda Glowacki, et al.JAMA Psychiatry|November 4, 2020
Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment: A Randomized Clinical TrialVictoria Manning, Joshua B B Garfield, Petra K Staiger, et al.Drug and Alcohol Review|July 30, 2026
Quitline Counsellors' Experiences With Vaping and Nicotine Replacement Therapy for Smoking Cessation in Australian Drug and Alcohol ServicesJane L Rich, Catherine J Segan, Joshua Trigg, et al.JMIR Research Protocols|July 17, 2020
Feasibility of a Mobile Health App for Routine Outcome Monitoring and Feedback in Mutual Support Groups Coordinated by SMART Recovery Australia: Protocol for a Pilot StudyPeter J Kelly, Alison K Beck, Amanda L Baker, et al.Biological Psychiatry Global Open Science|December 24, 2025
The Neurocircuitry of Cannabis Cue Reactivity in Cannabis Use Disorder: A Functional Neuroimaging StudyValentina Lorenzetti, Hannah Sehl, Arush Honnedevasthana Arun, et al.The Lancet. Public Health|July 2, 2025
Nicotine e-cigarettes for smoking cessation following discharge from smoke-free inpatient alcohol and other drug withdrawal services: a pragmatic two-arm, single-blinded, parallel-group, randomised controlled trialBillie Bonevski, Jane Rich, Dan I Lubman, et al.Psychopharmacology|May 7, 2026
A mindfulness-based intervention to reduce altered brain reward function in cannabis use disorder: a double-blind, active and passive, randomised controlled fMRI trialEmillie Beyer, Martine Skumlien, Govinda Poudel, et al.Pageof 23